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Effector CD8+ T cells scan tissues to locate and kill infected host cells. In this issue of Immunity, Hickman
et al. (2015) show that the exploration is not random: infected monocytes attract their assassins by secreting
chemokines, which accelerates clearance of epicutaneous vaccinia virus infection.During viral infections, effector CD8+
T cells patrol sites of inflammation and
scan host cells for evidence of infection.
Virally infected cells announce their in-
fected state to these effector CD8+ T cells
by presenting pathogen-derived peptides
on their surface major histocompatibility
complex (MHC) class I molecules, and
this requires contact between both cells.
Recognition by CD8+ T cells triggers elimi-
nation of the infected host cell, which takes
the virus down with it. The amazing thing
about this process is the vast number of
host cells that might need to be surveyed.
How do CD8+ T cells find infected targets
among millions of host cells? A number of
observed behaviors might increase the ef-
ficiency of this process. In cell-dense com-
partments, such as the epidermis, CD8+
T cells can adopt dendritic morphologies
to increase the number of cell contacts
(Ariotti et al., 2012). Effector T cells are
highlymotile withinmany infected nonlym-
phoid tissues (Mueller, 2013). Expression
of the inflammatory chemokine CXCL10,
which is one of two CXCR3 ligands in
C57BL/6 mice (CXCL9 is the other), hasalso been shown to increase the rate of
effector CD8+ T cell motility in the brain
during chronic Toxoplasma gondii infec-
tion (Harris et al., 2012). In this study,
effector CD8+ T cells have been shown
to exhibit specialized migration patterns
knownasLe`vywalks,which arecharacter-
ized by short steps within a small area and
occasional longer runs. Le`vy walks have
been proposed to increase the foraging
efficiency of marine predators, insects,
and human hunter-gatherers when food is
sparse (Raichlen et al., 2014; Viswanathan
et al., 1999). Le`vy walk behavior, although
still fundamentally random, is believed
to allow CD8+ T cells to find rare infected
targets with more than an order of magni-
tude more efficiency than random Brow-
nian motion walks (Harris et al., 2012). A
critical question is whether CD8+ T cells
searching within nonlymphoid sites of
infection are limited to random migration
behavior or whether they might also be
specifically directed toward infected cells
in some contexts.
Hickman et al. explored this question
after epicutaneously infecting mice withvaccinia virus, which replicates in both
epidermal keratinocytes and dermal in-
flammatory monocytes (Hickman et al.,
2013). They previously reported that
Ly6G+ innate immune cells are impor-
tant for clearance of virus from keratino-
cytic foci, whereas infected inflammatory
monocytes are targeted principally by
CD8+ T cells (Hickman et al., 2013). In
the current study, they investigated the
hypothesis that effector CD8+ T cells
within the dermis migrate toward chemo-
kine-mediated cries for help emanating
from infected cells.
After vaccinia virus infection, CD8+
T cells became activated and migrated to
the infected ear. Transcriptional profiling
revealed that compared to uninfected
controls, infected inflammatory mono-
cytes showed upregulation of chemokines
CXCL9 and CXCL10. The chemokine re-
ceptor CXCR3 is expressed on subsets
of effector and memory CD8+ T cells and
has been implicated in T cell priming,
effector differentiation, and migration.
Hickmanet al. found that CXCR3-deficient
mice exhibited a greater number of2, March 17, 2015 ª2015 Elsevier Inc. 399
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Figure 1. Hickman et al. Provide Evidence that Vaccinia-Infected Inflammatory Monocytes
Attract Effector CD8+ T Cells within the Dermis
This attraction depends on CXCR3-dependent CD8+ T cell chemotaxis toward CXCL9 and/or CXCL10
gradients produced by inflammatory monocytes upon infection, increasing the rapidity of viral control.
Cxcr3/ CD8+ T cells failed to follow this chemokine gradient (depicted by the wandering CD8+ T cell
in the lower right). These data support amodel by which virally infected hosts cells might contribute to their
own immunosurveillance and elimination by CD8+ T cells.
Immunity
Previewsinfected monocytes and delayed vaccinia
virus clearance. Although CXCR3 pro-
motes entry into inflamed tissues,
CXCR3-deficient CD8+ T cells were not
impaired in their trafficking into the
vaccinia-infected dermis. CXCR3 also fa-
cilitates tethering of T cells with antigen-
presenting cells andpromotes effector dif-
ferentiation (Friedman et al., 2006), but the
fact that no defects in effector potential
were observed after vaccinia infection
among CXCR3-deficient effector CD8+
T cells in the skin suggests an alternative
explanation for impaired viral control.
The authors then focused their atten-
tion on the in situ behavior of CD8+
T cells within the infected ear dermis.
Interestingly, they did not observe Le`vy
walks. However, in vivo multiphoton mi-
croscopy revealed altered CD8+ T cell
localization in the absence of CXCR3
(see Figure 1). Compared to wild-type
CD8+ T cells present in the same field,
the Cxcr3/ CD8+ T cells exhibited
impaired penetration into infected foci
and were less effective at forming stable400 Immunity 42, March 17, 2015 ª2015 Elsecontacts with virally infected targets.
Cxcr3/ CD8+ T cells also exhibited
higher motility rates than their wild-type
counterparts, consistent with the hypoth-
esis that CXCR3 plays a role in target cell
engagement, an event that arrests T cell
movement. Additional evidence also sup-
ported this interpretation. CD8+ T cells
synthesize interferon-g (IFN-g) upon
recognition of cognate antigen. Cxcr3/
CD8+ T cells were capable of expressing
wild-type amounts of IFN-g upon ex vivo
antigen stimulation. And in vivo, as indi-
cated by direct ex vivo intracellular cyto-
kine staining without further stimulation,
there was no observed difference in
IFN-g expression level between those
wild-type and Cxcr3/ effector CD8+
T cells that were expressing IFN-g. How-
ever, few Cxcr3/ CD8+ T cells synthe-
sized IFN-g within the vaccinia-infected
ear, which further bolstered the conclu-
sion that there was a failure to find and
engage antigen-bearing host cells. By
carefully titrating the number of wild-type
and CXCR3-deficient CD8+ T cells pre-vier Inc.sent in the ear and correlating this to the
frequency of infected cells, the authors
determined that Cxcr3/ CD8+ T cells
were only 25% as efficient at eliminating
viral targets. The authors further demon-
strated that the transfer of wild-type
CD8+ T cells rescued the delay in viral
clearance observed in Cxcr3/ hosts.
Previous studies have demonstrated
that CXCR3 plays a pivotal role in posi-
tioning central-memory CD8+ T cells to
areas of antigen encounter in lymphnodes
(Kastenmu¨ller et al., 2013; Sung et al.,
2012). Consequently, Cxcr3 memory
CD8+ T cells are impaired in controlling
lymph-borne virus. The current study ad-
vances this bodyof knowledge bydemon-
strating that this CXCR3-dependent inter-
action is crucial for actual engagement
of virally infected targets at a peripheral
site of infection. Importantly, this function
could be segregated from CXCR3-medi-
ated effector differentiation and extrava-
sation of CD8+ T cells into inflamed tissue
and provides evidence that at least in
some contexts, infected host cells might
play a key role in attracting their killers
and thus accelerating their own demise
for the betterment of the organism.
This study evokes a broader funda-
mental question: how many CD8+ T cells
does it take to completely survey an in-
fected tissue in order to ensure clearance
of all cells harboring intracellular virus?
Putatively, this could be modeled if one
measured the interaction rate between a
CD8+ T cell and host cells within a partic-
ular environment. Such sampling rates
might vary considerably within different
anatomic locations depending on the local
host cell density, steady-state CD8+ T cell
motility within that environment, and tran-
sientmodification of T cell motility rates by
inflammation-inducedchemokines aswell
as target-recognition-induced pausing
and execution of effector functions. How-
ever, Hickman et al. illustrate another very
significant variable. If infected target cells
participate in their own immunosurveil-
lance by attracting CD8+ T cells, this pro-
cess should be considerably more effi-
cient, and thus their finding highlights an
important concept that makes sense intu-
itively. However, it remains unknown in
which contexts this process occurs and
the degree to which the results might
generalize to other intracellular infections.
It is important to note that in this study, the
infected source of CXCL9 and CXCL10
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Previewswas a hematopoietic cell. When infected,
are all parenchymal cells equally endowed
with the ability to lure CD8+ T cells?
Target-mediated chemoattraction is also
likely to vary among different infections.
Indeed, viruses, including vaccinia, are
known to employ strategies that interfere
with chemotaxis. It will be important to
further determine the range of cues that
trigger and regulate this process within
thehost, thepotential involvement of other
chemokines, and the various strategies
that professional pathogens might utilize
to evade it. Nevertheless, by showing
that infected cells call their killers to the
scene of the crime, Hickman et al. high-
light a fundamental aspect of immunosur-
veillance in peripheral tissues.REFERENCES
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Cigarette smoke and infection are the major drivers of chronic obstructive pulmonary disease. In this issue of
Immunity, Kearley et al. (2015) demonstrate that smoke exposure alters the lung microenvironment leading
to an interleukin-33-dependent proinflammatory disease exacerbation.Chronic obstructive pulmonary disease
(COPD) is a chronic lung disorder with
irreversible and progressive airflow
obstruction associated with prolonged
and enhanced inflammatory response.
COPD is a major cause of morbidity and
mortality worldwide. Cigarette smoke
exposure is considered the primary
causative agent of COPD. The disease is
exacerbated by viral infections such as
rhinovirus or influenza virus or bacterial
infection. There is no effective treatment
for COPD. Inflammatory cytokines, inter-
feron-a (IFN-a), IFN-g, TNF-a, inter-
leukin-12 (IL-12), IL-23, IL-1a, and IL-18
have been implicated to play a role
in human COPD and mouse models.
However, the mechanism by which
smoking and infection interact to aggra-
vate COPD remains poorly understood.In this issue of Immunity, Kearley et al.
(2015) show that cigarette smoke alters
the lung microenvironment to facilitate
an alternative IL-33-dependent exagger-
ated proinflammatory response to infec-
tion leading to exacerbated COPD.
IL-33 is a member of the IL-1 family
(Schmitz et al., 2005), has an important
role in the induction and modulation of
immune responses, and has been linked
to a variety of inflammatory diseases,
such as rheumatoid arthritis, asthma,
and cardiovascular diseases (Liew et al.,
2010). Intracellular IL-33 is constitutively
expressed in the nuclei of a variety of
cell types, including epithelia, endothelia,
and fibroblasts, where it functions as a
nuclear factor with regulatory properties.
Mature IL-33 is released from the cells
normally after cell damage or necrosis.Extracellular IL-33 acts via its cognate
receptor ST2 that exists in membrane-
bound form (mST2) and signals via the
canonical IL-1R signaling cascade that
leads to activation of NF-kB and MAPK
signaling with subsequent induction
of proinflammatory immune responses
and cytokine production. By alternative
splicing of ST2, ST2 is also expressed in
a soluble form (sST2) lacking intracellular
signaling and thus functions as a decoy
receptor neutralizing IL-33 activity. Thus,
the immune system has evolved to detect
and regulate extracellular IL-33, which is
believed to function as an ‘‘alarmin’’ to
signal cellular damage. A recent study
showed that IL-33 is substantially
elevated in severe COPD patients (Byers
et al., 2013) and is associated with an IL-
13 and mucin gene-like signature.2, March 17, 2015 ª2015 Elsevier Inc. 401
